Overview

Lovastatin and Its ß-hydroxy Acid From Four 600 mg LipoCol Forte® Capsules Compared to That of One 20 mg Mevacor® Tablet in Healthy Subjects

Status:
Completed

Trial end date:
2006-10-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to evaluate the relative bioavailability of lovastatin and its ß-hydroxy acid of 600 mg LipoCol Forte® Capsules compared to that of one 20 mg Mevacor® Tablet after single oral administration in healthy subjects using a 2x2 crossover design.

Phase:

Phase 4

Details

Lead Sponsor:

Taipei Medical University WanFang Hospital

Treatments:

Dihydromevinolin
L 647318
Lovastatin